14 Patents
- US126066362026Treatment of Cancer Using Humanized Anti-cd19 Chimeric Antigen Receptor
The Trustees Of The University Of Pennsylvania
0 cites - US125943212026Bispecific Chimeric Antigen Receptor That Binds CD19 and CD20, Encoding Nucleic Acid Molecules Thereof and Methods of Use Thereof to Treat Cancer
The Trustees Of The University Of Pennsylvania
0 cites - US125595622026Treatment of Cancer Using Humanized Anti-egfrviii Chimeric Antigen Receptor
University Of Pittsburgh—of The Commonwealth System Of Higher Education
0 cites - 0 cites
- US123446572025CD20 Therapies, CD22 Therapies, and Combination Therapies with a CD19 Chimeric Antigen Receptor (car)-expressing Cell
The Trustees Of The University Of Pennsylvania
0 cites - US122140372025Treatment of Cancer Using Humanized Anti-bcma Chimeric Antigen Receptor
The Trustees Of The University Of Pennsylvania
0 cites - US121862782025Mesothelin Chimeric Antigen Receptor (CAR) and Antibody Against PD-L1 Inhibitor for Combined Use in Anticancer Therapy
President And Fellows Of Harvard College
0 cites - USRE0498472024Nucleic Acid Molecules Encoding Chimeric Antigen Receptors Comprising a CD20 Binding Domain
The Trustees Of The University Of Pennsylvania
0 cites - US118722492024Method of Treating Cancer by Administering Immune Effector Cells Expressing a Chimeric Antigen Receptor Comprising a CD20 Binding Domain
The Trustees Of The University Of Pennsylvania
0 cites - US118651672024Treatment of Cancer Using Humanized Anti-egfrviii Chimeric Antigen Receptor
University Of Pittsburgh—of The Commonwealth System Of Higher Education
0 cites - 0 cites
- US115914042023Treatment of Cancer Using a CD123 Chimeric Antigen Receptor
The Trustees Of The University Of Pennsylvania
0 cites - 0 cites
- US115424882023Sortase Synthesized Chimeric Antigen Receptors
The Trustees Of The University Of Pennsylvania
0 cites